This page tracks congressional stock trading activity in Astrana Health, Inc. (ASTH) in the Healthcare sector. Disclosed Capitol has indexed 2 disclosed congressional trades involving ASTH. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of August 2025 — Disclosed Capitol has tracked 2 disclosed congressional trades in Astrana Health, Inc. (ASTH) — 1:1 buy-heavy ratio — led by Judy Chu (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Aug 19, 2025 | Judy Chu | D | Sell | $100,001 - $250,000 |
| Aug 19, 2025 | Judy Chu | D | Buy | $100,001 - $250,000 |
Across the 2 disclosed congressional trades in Astrana Health, Inc. (ASTH), members of Congress have reported 1 buy and 1 sell. The average 30-day alpha vs. the S&P 500 is -3.51%.
As of October 2026, corporate insiders at Astrana Health, Inc. have filed 9 SEC Form 4 transactions in ASTH over the past 12 months.
| Date | Insider | Action | Value |
|---|---|---|---|
| 2026-10-06 | Sim Brandon — CEO and President | Tax Withholding | $366K |
| 2026-10-06 | Lam Thomas S. — Director | Tax Withholding | $97K |
| 2026-10-02 | Basho Chandan — COO and CFO | Tax Withholding | $75K |
| 2026-09-05 | Sim Brandon — CEO and President | Tax Withholding | $276K |
| 2026-09-05 | Basho Chandan — COO and CFO | Tax Withholding | $69K |
| 2026-08-31 | Kitayama Mitchell W — Director | Disposition to Issuer | $315K |
| 2026-08-14 | Schmidt David — Director | Option Exercise | $100K |
| 2026-08-14 | Schmidt David — Director | Disposition to Issuer | $772K |
| 2026-08-07 | Sobotka Glenn | Disposition to Issuer | — |
Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.
For fiscal year 2025, Astrana Health, Inc. reported revenue of $3.18B and net income of $22.5M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $1.94B, net income $34.2M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.